Risk Materials

Educational Risk Minimisation Materials to help reduce the risk associated with using this medicine.

RoActemra (tocilizumab) – Patient Brochure for Giant Cell Arteritis SC Formulation

This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan.

Send us feedback

If you would like to make a comment or send us feedback on this material, click here.